Products/Services Used | Details | Operation |
---|---|---|
Gene Synthesis> | The VpDef amino acid sequence, obtained from the Antimicrobial Peptide Database (ID: AP02514) (http://aps.unmc. edu/ AP/), was optimized for the expression in E. coli. The optimized sequence was synthesized by GenScript (New Jersey, United States of America), and the restriction sites NcoI and XhoI were added at the 5' end and 3' ends, respectively...For the removal of the fusion protein from the rVpDef peptide, 20 units of recombinant bovine His-enterokinase (Genscript) were added to 1 mg of the recombinant protein, and the resulting mix was incubated for 16 hours at 25°C... Once the recombinant protein was isolated (Figure 3), removal of the fusion protein was achieved by adding His-enterokinase (Genscript) and incubating for 16 h at 25°C. | Get A Quote |
Background: The heterologous production of antimicrobial peptides in bacterial models can produce insoluble proteins due to the lack of proper folding. Fusion proteins have been used to increase the expression and solubility of these types of proteins with varying degrees of success. Objectives: Here, we demonstrate the use of the small metal-binding proteins CusF3H+ (9.9kDa) and SmbP (9.9kDa) as fusion partners for the soluble expression of the bioactive antimicrobial peptide VpDef(6.9 kDa) in Escherichia coli. Methods: The recombinant VpDef (rVpDef) peptide was expressed as a translational fusion with CusF3H+ and SmbP in Escherichia coli SHuffle under different small-scale culture conditions. The best c... More